ABSTRACT
Phlorotannins are polyphenols occurring exclusively in some species of brown algae, known for numerous biological activities, e.g., antioxidant, antiproliferative, antidiabetic, and antiallergic properties. Their effects on the response of human lung cells to benzo[a]pyrene (B[a]P) has not been characterized. Our objective was to in vitro evaluate the effects of a phlorotannin-rich extract obtained from the brown algae Ascophyllum nodosum and Fucus vesiculosus on B[a]P cytotoxic effects. The A549 cell line was incubated with B[a]P for 48 and 72 h in the presence or absence of the brown algae extract. Cytochrome P450 activity, activation of P2X7 receptor, F-actin disorganization, and loss of E-cadherin expression were assessed using microplate cytometry and fluorescence microscopy. Relative to control, incubation with the brown algae extract was associated with lower B[a]P-induced CYP1 activity, lower P2X7 receptor activation, and lower reactive oxygen species production. The brown algae extract inhibited the alterations of F-actin arrangement and the downregulation of E-cadherin expression. We identified a phlorotannins-rich extract that could be deeper investigated as a cancer chemopreventive agent to block B[a]P-mediated carcinogenesis.
Subject(s)
Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/toxicity , Phaeophyceae , Receptors, Purinergic P2X7/metabolism , Tannins/pharmacology , A549 Cells , Chemoprevention/methods , Dose-Response Relationship, Drug , Humans , Tannins/isolation & purificationABSTRACT
Polycyclic aromatic hydrocarbons (PAHs) are environmental toxicants primarily produced during incomplete combustion; some are carcinogens. PAHs can be safely metabolized or, paradoxically, bioactivated via specific cytochrome P450 (CYP) enzymes to more reactive metabolites, some of which can damage DNA and proteins. Among the CYP isoforms implicated in PAH metabolism, CYP1A enzymes have been reported to both sensitize and protect from PAH toxicity. To clarify the role of CYP1A in PAH toxicity, we generated transgenic Caenorhabditis elegans that express CYP1A at a basal (but not inducible) level. Because this species does not normally express any CYP1 family enzyme, this approach permitted a test of the role of basally expressed CYP1A in PAH toxicity. We exposed C. elegans at different life stages to either the PAH benzo[a]pyrene (BaP) alone, or a real-world mixture dominated by PAHs extracted from the sediment of a highly contaminated site on the Elizabeth River (VA, USA). This site, the former Atlantic Wood Industries, was declared a Superfund site due to coal tar creosote contamination that caused very high levels (in the [mg/mL] range) of high molecular weight PAHs within the sediments. We demonstrate that CYP1A protects against BaP-induced growth delay, reproductive toxicity, and reduction of steady state ATP levels. Lack of sensitivity of a DNA repair (Nucleotide Excision Repair)-deficient strain suggested that CYP1A did not produce significant levels of DNA-reactive metabolites from BaP. The protective effects of CYP1A in Elizabeth River sediment extract (ERSE)-exposed nematodes were less pronounced than those seen in BaP-exposed nematodes; CYP1A expression protected against ERSE-induced reduction of steady-state ATP levels, but not other outcomes of exposure to sediment extracts. Overall, we find that in C. elegans, a basal level of CYP1A activity is protective against the examined PAH exposures.
Subject(s)
Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/toxicity , Caenorhabditis elegans/metabolism , Cytochrome P-450 CYP1A1/genetics , Polycyclic Aromatic Hydrocarbons/antagonists & inhibitors , Polycyclic Aromatic Hydrocarbons/toxicity , Water Pollutants, Chemical/toxicity , Zebrafish/metabolism , Adenosine Triphosphate/metabolism , Animals , Animals, Genetically Modified , Cytochrome P-450 CYP1A1/metabolism , DNA Repair/drug effects , Embryo, Nonmammalian , Larva/drug effects , Larva/growth & development , Molecular Weight , Reproduction/drug effectsABSTRACT
Genotoxic agents are capable of causing damage to genetic material and the cumulative DNA damage causes mutations, involved in the development of various pathological conditions, including cancer. Antigenotoxic agents possess the potential to counteract these detrimental cellular modifications and may aid in preventing, delaying, or decreasing the severity of these pathological conditions. An important class of natural products for which promising antigenotoxic activities have already been shown, are the flavonoids. In this research, we investigated the quantitative structure-activity relationship (QSAR) of flavonoids and their antigenotoxic activity against benzo[a]pyrene (B[a]P) and its mutagenic metabolite B[a]P-7,8-diol-9,10-epoxide-2. Random Forest classification models were developed, which could be useful as a preliminary in silico evaluation tool, before performing in vitro or in vivo experiments. The descriptors G2S and R8s. were the most significant for predicting the antigenotoxic potential.
Subject(s)
Benzo(a)pyrene/antagonists & inhibitors , DNA, Bacterial/drug effects , Drug Development , Flavonoids/pharmacology , Salmonella typhimurium/drug effects , DNA Damage , DNA, Bacterial/genetics , Dose-Response Relationship, Drug , Flavonoids/chemical synthesis , Flavonoids/chemistry , Models, Molecular , Molecular Structure , Quantitative Structure-Activity Relationship , Salmonella typhimurium/geneticsABSTRACT
Benzo[a]pyrene (B[a]P) is commonly associated with oxidative stress-induced neurotoxicity. Retinoic acid (RA) has been shown to exhibit neuroprotection in brain, and disruption of RA signaling via excess or deficient RA can lead to oxidative stress. B[a]P contamination in aquatic environment has been shown to lower the internal RA level. Thus, the present study was conducted in wild-type zebrafish to ameliorate the neurotoxic effect of B[a]P by waterborne RA co-supplementation. Findings showed that B[a]P induced anxiolytic-like behavioral response, and altered antioxidant activity in zebrafish is attenuated by RA. Our study also advocated the neurotoxic potential of RA treatment alone in control condition. Previous findings showed that periventricular gray zone (PGZ) of optic tectum (TeO) in zebrafish brain regulates anxiety-like behavior. The augmented pyknotic neuronal counts in PGZ following B[a]P treatment was ameliorated by RA co-supplementation. Further, presence of B[a]P in the cell milieu is known to induce oxidative stress through increase expression of cytochrome P450 1A1 (CYP1A1), an enzyme necessary for metabolic breakdown of both B[a]P and RA. Any deviation from the required concentration of RA leads to production of reactive oxygen species. Further, low availability of RA in cell milieu is known to decrease the expression of Nrf2, a transcription factor necessary for the expression of several antioxidants and antioxidant enzymes. Recent studies also showed that RA increases glutathione synthesis and exhibits neuroprotective properties in brain cells. The findings of the present study address the potential role of exogenous RA co-supplementation as a therapeutic intervention against B[a]P-induced depletion of RA, causing neurotoxicity in zebrafish.
Subject(s)
Benzo(a)pyrene/antagonists & inhibitors , Tretinoin/pharmacology , Animals , Anti-Anxiety Agents/toxicity , Antioxidants/toxicity , Apoptosis/drug effects , Behavior, Animal/drug effects , Benzo(a)pyrene/toxicity , Brain/metabolism , Catalase/metabolism , Female , Glutathione/metabolism , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Lipid Peroxidation/drug effects , Male , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Protein Carbonylation/drug effects , ZebrafishABSTRACT
Endocannabinoids are synthetized as a results of demand from membrane phospholipids. The formation and actions of these lipid mediators depend to a great extent on the prevalence of precursor fatty acid (FA), and can be influenced by diet or supplementation. The purpose of this study was to evaluate the interactive effects of lipopolysaccharide (LPS) and benzo(a)pyrene (BaP) in RAW 264.7 cells supplemented with docosahexaenoic acid (DHA). After LPS and/or BaP treatment in macrophages pre-incubated with DHA, a significant decrease in the amount of fatty acid was observed. The highest content of monounsaturated fatty acids was detected in RAW 264.7 cells co-treated with LPS and BaP. Significant interactions between LPS and BaP co-treatment in terms of endocannabinoid levels were observed in RAW 264.7 cells after DHA supplementation. The highest amount of endocannabinoids was detected in macrophages supplemented with DHA and co-treated with BaP and LPS: arachidonoyl ethanolamine AEA (5.9µg/mL), docosahexaenoyl ethanolamide DHEA (10.6µg/mL) and nervonoyl ethanolamide NEA (16.5µg/mL). The highest expression of cyclooxygenase (COX-2) and cannabinoid receptor 2 (CB2) was noted in macrophages supplemented with DHA and activated with LPS and BaP. Our data suggested a novel, CB2 receptor-dependent, environmental stress reaction in macrophages co-treated with LPS and BaP after supplementation with DHA. Despite the synergistic LPS and BaP action DHA potentiates the anti-inflammatory response in RAW 264.7 cells.
Subject(s)
Benzo(a)pyrene/antagonists & inhibitors , Carcinogens/antagonists & inhibitors , Docosahexaenoic Acids/metabolism , Endocannabinoids/antagonists & inhibitors , Lipopolysaccharides/antagonists & inhibitors , Macrophage Activation/drug effects , Macrophages/drug effects , Animals , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Anticarcinogenic Agents/metabolism , Arachidonic Acids , Benzo(a)pyrene/toxicity , Carcinogens/toxicity , Cyclooxygenase 2/chemistry , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Dietary Supplements , Drug Synergism , Endocannabinoids/metabolism , Fatty Acids, Monounsaturated/metabolism , Gene Expression Regulation/drug effects , Lipopolysaccharides/toxicity , Macrophages/immunology , Macrophages/metabolism , Mice , Polyunsaturated Alkamides , RAW 264.7 Cells , Receptor, Cannabinoid, CB2/agonists , Receptor, Cannabinoid, CB2/genetics , Receptor, Cannabinoid, CB2/metabolismABSTRACT
Benzo(a)pyrene [B(a)P] is an environmental toxicant that alters the steroidogenic profile of testis and induces testicular dysfunction. In the present study, we have investigated the molecular signaling of B(a)P and the ameliorative potential of the natural aryl hydrocarbon receptor (AhR) antagonist and antioxidant, resveratrol, on B(a)P-induced male reproductive toxicity. Studies showed that B(a)P treatment resulted in p38 MAPK activation and increased inducible nitric oxide synthase (iNOS) production along with testicular apoptosis and steroidogenic dysfunction. Resveratrol cotreatment maintained testicular redox potential, increased serum testosterone level and enhanced expression of major testicular steroidogenic proteins (CYPIIA1, StAR, 3ßHSD, 17ßHSD) and prevented subsequent onset of apoptosis. Resveratrol cotreatment resulted inhibition of testicular cytochrome P4501A1 (CYP1A1) expression, which is the major B(a)P metabolizing agent for BPDE-DNA adduct formation. Resveratrol also significantly decreased the B(a)P-induced AhR protein level, its nuclear translocation and subsequent promoter activation, thereby decreased the expression of CYP1A1. Resveratrol also down-regulated B(a)P-induced testicular iNOS production through suppressing the activation of p38 MAPK and ATF2, thus improved the oxidative status of the testis and prevented apoptosis. Our findings cumulatively suggest that resveratrol inhibits conversion of B(a)P into BPDE by modulating the transcriptional regulation of CYP1A1 and acting as an antioxidant thus prevents B(a)P-induced oxidative stress and testicular apoptosis.
Subject(s)
Antioxidants/therapeutic use , Benzo(a)pyrene/antagonists & inhibitors , Dietary Supplements , Environmental Pollutants/antagonists & inhibitors , Infertility, Male/prevention & control , Stilbenes/therapeutic use , Testis/drug effects , Activating Transcription Factor 2/agonists , Activating Transcription Factor 2/antagonists & inhibitors , Activating Transcription Factor 2/genetics , Activating Transcription Factor 2/metabolism , Active Transport, Cell Nucleus/drug effects , Animals , Antioxidants/adverse effects , Apoptosis/drug effects , Basic Helix-Loop-Helix Transcription Factors/agonists , Basic Helix-Loop-Helix Transcription Factors/antagonists & inhibitors , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/metabolism , Benzo(a)pyrene/administration & dosage , Benzo(a)pyrene/toxicity , Cytochrome P-450 CYP1A1/antagonists & inhibitors , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP1A1/metabolism , Dietary Supplements/adverse effects , Dose-Response Relationship, Drug , Environmental Pollutants/administration & dosage , Environmental Pollutants/toxicity , Gene Expression Regulation/drug effects , Infertility, Male/chemically induced , Infertility, Male/metabolism , Infertility, Male/pathology , MAP Kinase Signaling System/drug effects , Male , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Oxidative Stress/drug effects , Promoter Regions, Genetic/drug effects , Rats, Wistar , Receptors, Aryl Hydrocarbon/agonists , Receptors, Aryl Hydrocarbon/antagonists & inhibitors , Receptors, Aryl Hydrocarbon/genetics , Receptors, Aryl Hydrocarbon/metabolism , Resveratrol , Stilbenes/adverse effects , Testis/metabolism , Testis/pathology , Testosterone/agonists , Testosterone/antagonists & inhibitors , Testosterone/bloodABSTRACT
OBJECTIVE: The study was conducted to observe whether brain-derived neurotrophic factor (BDNF) has cytoprotective actions against alloxan (AL), streptozotocin (STZ), doxorubicin (DB) and benzo(a)pyrene (BP) compounds in vitro that may account for its beneficial action in diabetes mellitus. MATERIALS AND METHODS: This in vitro study was performed using rat insulinoma (RIN5F) cells. Possible cytoprotective action of BDNF (using pre-treatment, simultaneous and post-treatment schedules of RIN5F cells with BDNF) against the four chemicals tested was evaluated using MTT and apoptosis assays. Possible mechanism of cytoprotective action of BDNF was assessed by measuring BCl2/IKB-ß/Pdx mRNA transcripts and anti-oxidant levels in RIN5F cells. Effect of alloxan, STZ, doxorubicin and BP on the production of BDNF by RIN5F cells was also studied. RESULTS: Results of the present study revealed that BDNF in the doses (100ng>50ng>10ng/ml) has significant cytoprotection (P<0.001, P<0.01) on cytotoxic action of AL, STZ, DB and BP against rat insulinoma RIN5F (5×10(4) cells/100µl) cells in vitro. It was observed that AL, STZ, DB and BP inhibited BDNF production significantly (P<0.001) in a dose-dependent manner by RIN5F cells (0.5×10(6) cells/500µl) in vitro, while BDNF not only prevented apoptosis induced by these four chemicals but also significantly increased (P<0.001) BCl2/IKB-ß/Pdx mRNA transcripts and restored anti-oxidant levels (P<0.01) in RIN5F cells to normal. DISCUSSION: These results suggest that BDNF has potent cytoprotective actions, restores anti-oxidant defenses to normal and thus, prevents apoptosis and preserves insulin secreting capacity of ß cells. In addition, BDNF enhanced viability of RIN 5F in vitro. Thus, BDNF not only has anti-diabetic actions but also preserves pancreatic ß cells integrity and enhances their viability. These results imply that BDNF functions as an endogenous cytoprotective molecule that may explain its beneficial actions in some neurological conditions as well.
Subject(s)
Alloxan/antagonists & inhibitors , Apoptosis/drug effects , Brain-Derived Neurotrophic Factor/metabolism , Insulin-Secreting Cells/drug effects , Models, Biological , Streptozocin/antagonists & inhibitors , Alloxan/toxicity , Animals , Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/toxicity , Brain-Derived Neurotrophic Factor/antagonists & inhibitors , Brain-Derived Neurotrophic Factor/genetics , Cell Line, Tumor , Cell Survival/drug effects , Doxorubicin/antagonists & inhibitors , Doxorubicin/toxicity , Drug Resistance , Gene Expression Regulation/drug effects , Humans , Insulin/metabolism , Insulin Secretion , Insulin-Secreting Cells/metabolism , Kinetics , Poisons/chemistry , Poisons/toxicity , Rats , Recombinant Proteins/metabolism , Streptozocin/toxicityABSTRACT
As is ubiquitous in the environmental sources, benzo(a)pyrene (BaP) has been reported to induce reprotoxicity in previous studies. Toxicity to trophoblast cells may be one key factor, but evidences were absent. We speculated that BaP can induce cytotoxicity in human trophoblast HTR-8/SVneo (HTR) cells, and Schisandrin B (Sch B) as a potential protector can inhibit the cytotoxicity. MTS assay identified that BaP induced HTR cells death while Sch B played a cytoprotective role. And after Nrf2 interference, the ability of Sch B-induced cytoprotection was declined. Furthermore, PCR, western blot, ELISA, and SOD assays were found that Sch B significantly increased the mRNA and protein expression of Nrf2, HO1, NQO1, and SOD in the Nrf2-ARE pathway, and the extents of increase were declined after Nrf2 interference. These results demonstrated that the Nrf2-ARE pathway plays an important role in Sch B attenuating BaP-induced HTR cells damages in vitro. © 2015 Wiley Periodicals, Inc. Environ Toxicol 31: 1439-1449, 2016.
Subject(s)
Benzo(a)pyrene/antagonists & inhibitors , Cytoprotection , Lignans/pharmacology , NF-E2-Related Factor 2/physiology , Polycyclic Compounds/pharmacology , Trophoblasts/drug effects , Antioxidant Response Elements/drug effects , Benzo(a)pyrene/toxicity , Cell Line , Cyclooctanes/pharmacology , Female , Humans , NF-E2-Related Factor 2/antagonists & inhibitors , NF-E2-Related Factor 2/genetics , RNA, Small Interfering/genetics , Signal Transduction/drug effects , Signal Transduction/genetics , Trophoblasts/physiologyABSTRACT
The present report was designed to determine the antigenotoxic capacity of beta-caryophyllene (BC) on the damage induced by benzo(a)pyrene (BaP) in mouse. We found no genotoxic potential of BC, and a significant inhibitory effect on the number of sister-chromatid exchanges (SCE) and chromosomal aberrations induced by BaP. The three tested doses of the agent (20, 200, and 2,000 mg/kg) produced a dose-dependent decrease of the two evaluated cytogenetic parameters. In comparison with the effect induced by BaP, the best inhibitory effect (about 80%) was obtained with the high tested dose of BC considering the two evaluated parameters. Other aim of the study was to explore whether in this effect participated the BC antioxidant capacity and/or its effect as inducer of GST activity. We found a dose-dependent decrease induced by BC in regard to both the oxidation of lipids and proteins produced by BaP.In the case of GST, when BC was administered alone we found a mean increase of 64% of the enzyme activity, respect to the control level, and when BC was administered in mice treated with BaP the increase obtained with the high dose of BC reached 27%. Therefore, our data established no in vivo genotoxicity by BC, and a significant antigenotoxic potential of the compound, which may be related with its capacity to block the molecular oxidation and to stimulate the GST activity.
Subject(s)
Antioxidants , Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/toxicity , Bone Marrow Cells/drug effects , Environmental Pollutants/antagonists & inhibitors , Environmental Pollutants/toxicity , Glutathione Transferase/biosynthesis , Sesquiterpenes/pharmacology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/enzymology , Carcinogens, Environmental , Cells, Cultured , Chromosome Aberrations/drug effects , Dose-Response Relationship, Drug , Enzyme Induction/drug effects , Male , Mice , Mutagenicity Tests , Polycyclic Sesquiterpenes , Sesquiterpenes/chemistry , Sister Chromatid Exchange/drug effectsABSTRACT
Benzo[alpha]pyrene (B[α]P) was used to test the possible antimutagenic effects of Arthrospira (Spirulina) maxima (SP) on male and female mice. SP was orally administered at 0, 200, 400, or 800 mg/kg of body weight to animals of both sexes for 2 weeks before starting the B[α]P (intraperitoneal injection) at 125 mg/kg of body weight for 5 consecutive days. For the male dominant lethal test, each male was caged with two untreated females per week for 3 weeks. For the female dominant lethal test, each female was caged for 1 week with one untreated male. All the females were evaluated 13-15 days after mating for incidence of pregnancy, total corpora lutea, total implants and pre- and postimplant losses. SP protected from B[α]P-induced pre- and postimplant losses in the male dominant lethal test, and from B[α]P-induced postimplantation losses in treated females. Moreover, SP treatment significantly reduced the detrimental effect of B[α]P on the quality of mouse semen. Our results illustrate the protective effects of SP in relation to B[α]P-induced genetic damage to germ cells. We conclude that SP, owing mainly to the presence of phycocyanin, could be of potential clinical interest in cancer treatment or prevention of relapse.
Subject(s)
Antimutagenic Agents/analysis , Benzo(a)pyrene/antagonists & inhibitors , Diet , Spirulina , Abortion, Veterinary/prevention & control , Animals , Antimutagenic Agents/administration & dosage , Breeding , Dietary Supplements , Female , Male , Mice , Mutagenicity Tests , Mutagens , Ovum/drug effects , Phycocyanin/administration & dosage , Pregnancy , Spermatozoa/abnormalities , Spermatozoa/drug effectsABSTRACT
The plant Houttuynia cordata, which is called "dokudami" in Japanese, is known as a potent antioxidant herb that has been traditionally consumed as a folk medicine for various ailments, such as diabetes, obesity, cough, fever and skin diseases, in Asia. However, its antioxidant mechanism remains largely unknown. In the present study, we investigated the effects of Houttuynia cordata extract (HCE) on human keratinocytes. HCE activated aryl hydrocarbon receptor (AHR) and nuclear factor E2-related factor 2, with subsequent induction of the antioxidative enzyme NAD (P)H: quinone oxidoreductase 1 gene. HCE inhibited the generation of reactive oxygen species (ROS) in keratinocytes stimulated with tumor necrosis factor α or benzo(α)pyrene. Moreover, HCE upregulated the gene expression of filaggrin, an essential skin barrier protein, in an AHR-dependent manner. HCE may be beneficial for treating ROS-related photoaging and barrier-disrupted skin conditions.
Subject(s)
Antioxidants , Drugs, Chinese Herbal/pharmacology , Gene Expression/drug effects , Intermediate Filament Proteins/genetics , Keratinocytes/metabolism , Receptors, Aryl Hydrocarbon/metabolism , Up-Regulation/drug effects , Benzo(a)pyrene/antagonists & inhibitors , Cells, Cultured , Epidermal Cells , Filaggrin Proteins , Houttuynia , Humans , Intermediate Filament Proteins/metabolism , NAD(P)H Dehydrogenase (Quinone)/metabolism , NADP/metabolism , NF-E2-Related Factor 2/metabolism , Reactive Oxygen Species/metabolism , Tumor Necrosis Factor-alpha/antagonists & inhibitorsABSTRACT
BACKGROUND: Honey contains a variety of polyphenols and represents a good source of antioxidants, while the human diet often contains compounds that can cause DNA damage. The present study investigated the protective effect of three commercial honey samples of different floral origin (rosemary, heather and heterofloral) from Madrid Autonomic Community (Spain) as well as an artificial honey on DNA damage induced by dietary mutagens, using a human hepatoma cell line (HepG2) as in vitro model system and evaluation by the alkaline single-cell gel electrophoresis or comet assay. RESULTS: Rosemary, heather and heterofloral honeys protected against DNA strand breaks induced by N-nitrosopyrrolidine (NPYR), benzo(a)pyrene (BaP) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), but none of the honey samples tested prevented DNA strand breaks induced by N-nitrosodimethylamine (NDMA). Heterofloral and heather (unifloral) honeys with higher phenolic content were most effective in protecting HepG2 cells against DNA damage induced by food mutagens. Heterofloral honey was more protective against NPYR and BaP, while heather honey was more protective against PhIP. Artificial honey did not show a protective effect against DNA damage induced by any of the food mutagens tested, indicating that the protective effects of honeys could not be due to their sugar components. CONCLUSION: The results suggest that the protective effect of three kinds of Spanish honey of different floral origin could be attributed in part to the phenolics present in the samples. Honeys with higher phenolic content, i.e. heather and heterofloral honeys, were most effective in protecting against food mutagen-induced DNA damage in HepG2 cells. In addition, a possible synergistic effect between other minor honey components could also be involved.
Subject(s)
Anticarcinogenic Agents/metabolism , DNA Damage , Food Contamination , Functional Food , Honey , Liver Neoplasms/prevention & control , Mutagens/toxicity , Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/toxicity , Cell Survival/drug effects , Comet Assay , DNA Breaks/drug effects , Ericaceae/metabolism , Functional Food/analysis , Hep G2 Cells , Honey/analysis , Humans , Imidazoles/antagonists & inhibitors , Imidazoles/toxicity , Liver Neoplasms/chemically induced , Liver Neoplasms/metabolism , Models, Biological , Mutagens/chemistry , N-Nitrosopyrrolidine/chemistry , N-Nitrosopyrrolidine/toxicity , Phenols/analysis , Phenols/metabolism , Rosmarinus/metabolism , SpainABSTRACT
Betanin, also called beetroot red, has been extensively used as a food colorant. In this study, the chemopreventive activity of betanin by oral consumption was investigated in two mouse lung tumor models. Vinyl carbamate (VC) and benzo(a)pyrene (B(a)P) were used to induce lung tumors, and female A/J mice were treated with betanin in drinking water. Betanin significantly decreased tumor multiplicity and tumor load induced by both carcinogens. Tumor multiplicity and tumor load were decreased by 20% and 39% in the VC lung model, and by 46% and 65% in the B(a)P lung model, respectively. Betanin reduced the number of CD31+ endothelial microvessels and increased the expression of caspase-3, suggesting that the lung tumor inhibitory effects were through induction of apoptosis and inhibition of angiogenesis. Betanin also induced apoptosis through activated caspase-3, -7, -9, and PARP in human lung cancer cell lines. Our data show that betanin significantly inhibits lung tumorigenesis in A/J mice and merits investigation as a chemopreventive agent for human lung cancer.
Subject(s)
Apoptosis/drug effects , Betacyanins/pharmacology , Cell Transformation, Neoplastic/drug effects , Lung Neoplasms/drug therapy , Animals , Anticarcinogenic Agents/pharmacology , Apoptosis/genetics , Benzo(a)pyrene/antagonists & inhibitors , Caspases/genetics , Caspases/metabolism , Cell Transformation, Neoplastic/chemically induced , Cell Transformation, Neoplastic/pathology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Female , Lung Neoplasms/blood supply , Lung Neoplasms/chemically induced , Lung Neoplasms/pathology , Mice , Mice, Inbred A , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Platelet Endothelial Cell Adhesion Molecule-1/genetics , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Poly(ADP-ribose) Polymerases/genetics , Poly(ADP-ribose) Polymerases/metabolism , Random Allocation , Urethane/analogs & derivatives , Urethane/antagonists & inhibitorsABSTRACT
Diallyl trisulfide (DATS) is a garlic organosulfide that is toxic to cancer cells, however, little is known about its effect in the initiation phase of carcinogenesis. We sought to determine whether DATS could inhibit the carcinogen, benzo(a)pyrene (BaP), from inducing precancerous activity, in vitro. MCF-10A cells were either pre-treated (PreTx) or concurrently treated (CoTx) with 1 µM BaP, and 6 or 60 µM DATS for up to 24h. The DATS 6 and 60 µM CoTx inhibited BaP-induced cell proliferation by an average of 71.1% and 120.8%, respectively, at 6h. The 60 µM DATS pretreatment decreased BaP-induced G2/M cell cycle transition by 127%, and reduced the increase in cells in the S-phase by 42%; whereas 60 µM DATS CoTx induced a 177% increase in cells in G1. DATS effectively inhibited (P<0.001) BaP-induced peroxide formation by at least 54%, which may have prevented the formation of BaP-induced DNA strand breaks. In this study, we reveal mechanisms involved in DATS inhibition of BaP-induced carcinogenesis, including inhibition of cell proliferation, regulation of cell cycle, attenuation of ROS formation, and inhibition of DNA damage. At the doses evaluated, DATS appears to be an effective attenuator of BaP-induced breast carcinogenesis, in vitro.
Subject(s)
Allyl Compounds/pharmacology , Benzo(a)pyrene/antagonists & inhibitors , Cell Transformation, Neoplastic , Sulfides/pharmacology , Benzo(a)pyrene/toxicity , Cell Line, Tumor , Comet Assay , DNA Damage , Flow Cytometry , HumansABSTRACT
A549 cells were pre-incubated with ß-carotene (BC) alone or in combination with quercetin or three major quercetin metabolites in human plasma, quercetin 3-glucuronide (Q3G), quercetin 3'-sulphate (Q3'S) and isorhamnetin, followed by incubation with benzo[a]pyrene (BaP), to investigate the effects of these compounds on the BaP-induced harmful effects of BC. All the quercetin metabolites at 10µM inhibited BaP+BC-induced cell death. Q3'S, Q3G and isorhamnetin also significantly decreased BaP±BC-induced DNA damage by 64%, 60% and 24%, respectively. In a similar order, these compounds suppressed BaP+BC-induced cytochrome P450 (CYP)1A1/1A2 expression by 10-50%. Q3G and Q3'S significantly decreased the intracellular reactive oxygen species formation induced by BaP+BC; however, Q3G had the best effect on decreasing the loss of BC induced by Fe/NTA. The combined effects of quercetin metabolites were additive. This study indicates that quercetin metabolites decrease the BaP-induced harmful effect of ß-carotene in A549 cells by downregulating the expression of CYP1A1/1A2, at least in part.
Subject(s)
Cytochrome P-450 CYP1A1/biosynthesis , Cytochrome P-450 CYP1A2/biosynthesis , DNA Damage , Quercetin/analogs & derivatives , Quercetin/pharmacology , beta Carotene/pharmacology , Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/toxicity , Cell Line, Tumor , Drug Interactions , Humans , Quercetin/metabolism , Reactive Oxygen Species/metabolismABSTRACT
Benzo(a)pyrene [B(a)P] is known to alter lung physiology by interfering in various intracellular pathways including alterations in NF-κB activities, cytokine release and cell survival. NF-κB suppression/activation plays a major role in cell survival status. Present investigation deals with such kind of effects of B(a)P on lungs in relation with soluble epoxide hydrolase (sEH) and thioredoxin reductase (TrxR) activities. Glycyrrhizic acid (GA), an active principle of Glycyrrhiza glabra (Licorice), is known to modulate various molecular processes. In the present study, we investigated the protective effects of GA against B(a)P induced debilities in lungs of Wistar rats. Intratracheal instillation of B(a)P significantly suppressed NF-κB translocation, sEH, TrxR and catalase activities in lung tissue. A marked induction of H(2)O(2) levels along with caspases activation (caspases-2, -3, -6, -8, and -9) in lung tissue after B(a)P exposure was observed. Lung injury was assessed by measuring lactate dehydrogenase (LDH), alkaline phosphatase (ALP), total cell count, total protein, neutrophil elastase activity in bronchoalveolar lavage fluid (BALF). Reduction in phospholipid content further potentiated these parameters. GA oral administration (50 and 100mg/kg b.wt.) significantly showed protection of lung epithelium by suppression of caspases activities in lung tissue and reduction of total protein, total cells, elastase activity, LDH and ALP activities along with fortification of phospholipids in BALF. Histological observations also confirm the findings in above mentioned parameters. Results indicate a strong correlation between amelioration of sEH and TrxR activities, and NF-κB activation. The present investigation gives an insight into probable mechanisms of lung injuries induced by short term exposures of B(a)P and prevention by glycyrrhizic acid.
Subject(s)
Acute Lung Injury/chemically induced , Acute Lung Injury/prevention & control , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/toxicity , Environmental Pollutants/toxicity , Epoxide Hydrolases/metabolism , Glycyrrhizic Acid/pharmacology , Thioredoxin-Disulfide Reductase/metabolism , Acute Lung Injury/pathology , Alkaline Phosphatase/metabolism , Animals , Apoptosis/drug effects , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Caspases/metabolism , Cell Count , Cell Nucleus/metabolism , Cytosol/metabolism , Dose-Response Relationship, Drug , Indicators and Reagents , L-Lactate Dehydrogenase/metabolism , Leukocyte Elastase/metabolism , Male , NF-kappa B/metabolism , Necrosis , Phospholipids/metabolism , Pulmonary Edema/chemically induced , Pulmonary Edema/pathology , Rats , Rats, WistarABSTRACT
This study was designed to investigate the molecular mechanism underlying the chemopreventive effects of methionine on benzo[a]pyrene (B[a]P)-DNA adducts formation in HepG2 cells. Methionine significantly inhibited B[a]P-DNA adduct formation in HepG2 cells. Methionine significantly decreased the cellular uptake of [(3)H] B[a]P, but increased the cellular discharge of [(3)H] B[a]P from HepG2 cells into the media. B[a]P significantly lowered total cellular glutathione (GSH) level, but co-cultured with B[a]P and methionine, gradually attenuated intracellular GSH levels in a concentration-dependent manner, which was markedly higher at 20-500µM methionine. The cellular proteins of treated cells were resolved by 2D-polyacrylamide gel electrophoresis. Proteomic profiles showed that phase II enzymes such as glutathione S-transferase (GST) omega-1, GSTM3, glyoxalase I (GLO1) and superoxide dismutase (SOD) were down-regulated by B[a]P treatment, whereas cathepsin B (CTSB), Rho GDP-dissociation inhibitor alpha (Rho-GDP-DIA), histamine N-methyltransferase (HNMT), spermidine synthase (SRM) and arginase-1 (ARG1) were up-regulated by B[a]P. B[a]P and methionine treatments, GST omega-1, GSTM3, GLO1 and SOD were significantly enhanced compared to B[a]P alone. Similarly, methionine was effective in diminishing the B[a]P-induced up-regulation of CTSB, Rho-GDP-DIA, HNMT, SRM and ARG1. Our data suggests that methionine might exert a chemoprotective effect on B[a]P-DNA adduct formation by attenuating intracellular GSH levels, blocking the uptake of B[a]P into cells, or by altering expression of proteins involved in DNA adduct formation.
Subject(s)
Benzo(a)pyrene/antagonists & inhibitors , DNA Adducts/antagonists & inhibitors , Liver Neoplasms/chemically induced , Methionine/pharmacology , Proteomics/methods , Arginase/analysis , Cathepsin B/analysis , DNA Adducts/biosynthesis , Glutathione Transferase/analysis , Guanine Nucleotide Dissociation Inhibitors/analysis , Hep G2 Cells , Histamine N-Methyltransferase/analysis , Humans , Lactoylglutathione Lyase/analysis , Liver Neoplasms/enzymology , Liver Neoplasms/genetics , Liver Neoplasms/metabolism , Spermidine Synthase/analysis , Superoxide Dismutase/analysis , rho-Specific Guanine Nucleotide Dissociation InhibitorsABSTRACT
Multi-drug resistance protein (MRP) 4, an ATP-binding cassette (ABC) transporter, has broad substrate specificity. It facilitates the transport of bile salt conjugates, conjugated steroids, nucleoside analogs, eicosanoids, and cardiovascular drugs. Recent studies in liver carcinoma cells and hepatocytes showed that MRP4 expression is regulated by the aryl hydrocarbon receptor (AhR) and nuclear factor E2-related factor 2 (Nrf2). The AhR has particular importance in the lung and is most commonly associated with the up-regulation of cytochrome P-450 (CYP)-mediated metabolism of benzo[a]pyrene (B[a]P) to reactive intermediates. Treatment of H358, human bronchoalveolar, cells with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or (-)-benzo[a]pyrene-7,8-dihydro-7,8-diol (B[a]P-7,8-dihydrodiol), the proximate carcinogen of B[a]P, revealed that MRP4 expression was increased compared to control. This suggested that MRP4 expression might contribute to the paradoxical decrease in (+)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-2'-deoxyguanosine ((+)-anti-trans-B[a]PDE-dGuo) DNA-adducts observed in TCDD-treated H358 cells. We have now found that decreased MRP4 expression induced by a short hairpin RNA (shRNA), or chemical inhibition with probenecid, increased (+)-anti-trans-B[a]PDE-dGuo formation in cells treated with (-)-B[a]P-7,8-dihydrodiol, but not the ultimate carcinogen (+)-anti-trans-B[a]PDE. Thus, up-regulation of MRP4 increased cellular efflux of (-)-B[a]P-7,8-dihydrodiol, which attenuated DNA-adduct formation. This is the first report identifying a specific MRP efflux transporter that decreases DNA damage arising from an environmental carcinogen.
Subject(s)
Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/toxicity , Bronchi/cytology , Carcinogens/antagonists & inhibitors , Carcinogens/toxicity , DNA Adducts/drug effects , Multidrug Resistance-Associated Proteins/pharmacology , Pulmonary Alveoli/cytology , Bronchi/drug effects , Bronchoalveolar Lavage Fluid/cytology , Cell Line , DNA/genetics , DNA/isolation & purification , Dinoprostone/biosynthesis , Humans , Immunohistochemistry , NF-E2-Related Factor 2/metabolism , Polychlorinated Dibenzodioxins/toxicity , Probenecid/pharmacology , Pulmonary Alveoli/drug effects , RNA, Small Interfering/biosynthesis , RNA, Small Interfering/genetics , Real-Time Polymerase Chain Reaction , Receptor Cross-Talk/drug effects , Receptors, Aryl Hydrocarbon/drug effects , Renal Agents/pharmacology , Signal Transduction/drug effectsABSTRACT
The polyphenolics in green tea are believed to be the bioactive components. However, poor bioavailability following ingestion limits their efficacy in vivo. In this study, polyphenon E (poly E), a standardized green tea extract, was administered by sustained-release polycaprolactone implants (two, 2-cm implants; 20% drug load) grafted subcutaneously or via drinking water (0.8% w/v) to female S/D rats. Animals were treated with continuous low dose of benzo[a]pyrene (BP) via subcutaneous polymeric implants (2 cm; 10% load) and euthanized after 1 and 4 weeks. Analysis of lung DNA by (32)P-postlabeling resulted in a statistically significant reduction (50%; p = 0.023) of BP-induced DNA adducts in the implant group; however, only a modest (34%) but statistically insignificant reduction occurred in the drinking water group at 1 week. The implant delivery system also showed significant reduction (35%; p = 0.044) of the known BP diolepoxide-derived DNA adduct after 4 weeks. Notably, the total dose of poly E administered was >100-fold lower in the implant group than the drinking water group (15.7 versus 1,632 mg, respectively). Analysis of selected phase I, phase II, and nucleotide excision repair enzymes at both mRNA and protein levels showed no significant modulation by poly E, suggesting that the reduction in the BP-induced DNA adducts occurred presumably due to known scavenging of the antidiolepoxide of BP by the poly E catechins. In conclusion, our study demonstrated that sustained systemic delivery of poly E significantly reduced BP-induced DNA adducts in spite of its poor bioavailability following oral administration.
Subject(s)
Benzo(a)pyrene/toxicity , Carcinogens, Environmental/toxicity , Catechin/analogs & derivatives , DNA Adducts/metabolism , Drug Implants , Tea/chemistry , Animals , Benzo(a)pyrene/antagonists & inhibitors , Benzo(a)pyrene/metabolism , Catechin/administration & dosage , Catechin/pharmacology , DNA Adducts/antagonists & inhibitors , DNA Repair/drug effects , Drug Implants/chemistry , Female , Lung/drug effects , Lung/enzymology , Lung/metabolism , Polyesters/chemistry , Rats , Rats, Sprague-DawleyABSTRACT
Abstract: Present study evaluated the anti-clastogenic efficacy of Azadirchta indica (A. indica) against benzo(a)pyrene [B(a)P] in murine forestomach tumorigenesis bioassay protocol. Female Balb/c mice were divided into four groups (n = 8). Each mouse from B(a)P and B(a)P + A. indica groups received intragastric instillations of B(a)P at a dose of 40 mg/kg b. w. in 0.2 mL olive oil twice a week, starting from 3rd week to the end of 6th week of the experiment. Mice of control and A. indica groups received 0.2 mL olive oil in the same schedule as for B(a)P and B(a)P + A indica groups. Mice of A. indica and B(a)P + A. indica groups received oral doses of 100 mg/kg b. w. aqueous A. indica leaf extract (AAILE) on alternate days throughout the experiment. Two weeks after the last B(a)P instillation, mice were sacrificed and spleens were processed for micronucleus (MN) assay, while liver tissues were analyzed for lipid peroxidation (LPO), as well as antioxidant defense enzymes, namely: catalase, superoxide dismutase (SOD), glutathione reductase (GR) and glutathione peroxidase (GPx). The incidence of MN formation increased in spleen cells of mice that received only B(a)P instillations. In hepatic tissues, the extent of oxidative stress increased upon B(a)P instillations as was evidenced from enhanced LPO levels with concomitant decrease in antioxidant defense enzyme activities in mice that received only B(a)P instillations. Interestingly, A. indica treatment significantly reversed these effects as observed in mice receiving AAILE along with B(a)P when compared to only B(a)P receiving mice. Moreover, in only AAILE receiving mice, enhanced antioxidant defense with slightly decreased levels of LPO as well as MN incidences were observed. Observations of the present study suggest that A. indica exert anticlastogenic effects against B(a)P by modulating oxidative stress and antioxidant defense.